Representative animal models | Â | Methods | Species | Experimental period | Peritoneal dysfunction | Neoangiogenesis | Fibrosis | EPS | References |
---|---|---|---|---|---|---|---|---|---|
Peritonitis model | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Infectious model | Bacteria | Staphylococcus aureus | Mouse | 2 days | No report | No report | No report | − | [14] |
Rat | 2 weeks | No report | No report | ± | − | ||||
 |  | Staphylococcus epidermidis | Mouse | 2 weeks | No report | No report | No report | − | [20] |
 |  | Pseudomonas aeruginosa | Rat | 1 week | No report | No report | No report | − | [21] |
 | Fungus | Candida albicans | Mouse | 1 day | No report | No report | No report | − | [22] |
 | Performance without aseptic precautions |  | Mouse | 1 week | + | + | No report | − | [23] |
Rat | 1 week | + | + | No report | − | ||||
Non-infectious model |  | LPS | Mouse | 1 day | + | No report | No report | − | |
Rat | 1 day | + | No report | No report | − | ||||
 |  | PDF with LPS | Rat | 3–6 weeks | + | + | + | − | |
 |  | SES | Mouse | 2 days | No report | No report | No report | − | |
 |  | Scraping | Rat | 2 weeks | + | + | + | − | |
 |  | Zymosan with scraping | Rat | 5 weeks | No report | + | + | ± | |
 |  | Mouse | 4–5 weeks | + | + | + | − | ||
Rat | 1–20 weeks | + | + | + | − | ||||
 |  | Chlorhexidine | Mouse | 1–8 weeks | + | + | + | + | |
Rat | 1–8 weeks | + | + | + | + | ||||
 |  | Methylglyoxal | Mouse | 3–7 weeks | + | + | + | + | |
Rat | 3Â weeks | + | + | + | + | ||||
 |  | TGF-β1 | Mouse | 1–10 weeks | No report | + | + | + | |
Rat | 1–4 weeks | + | + | + | − |